These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 2899773)
1. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Mamelle N; Meunier PJ; Dusan R; Guillaume M; Martin JL; Gaucher A; Prost A; Zeigler G; Netter P Lancet; 1988 Aug; 2(8607):361-5. PubMed ID: 2899773 [TBL] [Abstract][Full Text] [Related]
2. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438 [TBL] [Abstract][Full Text] [Related]
3. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957 [TBL] [Abstract][Full Text] [Related]
4. Radiographic features of the spine in fluoride therapy for osteoporosis. Schnitzler CM; Sweet MB; Blumenfeld TS; Isaacson DC J Bone Joint Surg Br; 1987 Mar; 69(2):190-4. PubMed ID: 3818747 [TBL] [Abstract][Full Text] [Related]
5. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071 [TBL] [Abstract][Full Text] [Related]
6. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. Reeve J; Davies UM; Hesp R; McNally E; Katz D BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738 [TBL] [Abstract][Full Text] [Related]
7. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. Riggs BL; Seeman E; Hodgson SF; Taves DR; O'Fallon WM N Engl J Med; 1982 Feb; 306(8):446-50. PubMed ID: 6276746 [TBL] [Abstract][Full Text] [Related]
8. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549 [TBL] [Abstract][Full Text] [Related]
9. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. Nagant de Deuxchaisnes C; Devogelaer JP; Depresseux G; Malghem J; Maldague B J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327 [TBL] [Abstract][Full Text] [Related]
10. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry. Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736 [TBL] [Abstract][Full Text] [Related]
11. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445 [TBL] [Abstract][Full Text] [Related]
12. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624 [TBL] [Abstract][Full Text] [Related]
13. Effect of intermittent therapy with a slow-release fluoride preparation. Pak CY; Sakhaee K; Zerwekh JE J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625 [TBL] [Abstract][Full Text] [Related]
14. [The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium]. Meunier PJ Fortschr Med; 1990 Jan; 108(1):45-8. PubMed ID: 2179080 [TBL] [Abstract][Full Text] [Related]
15. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491 [TBL] [Abstract][Full Text] [Related]
17. [Toward a rational use of fluoride in treating common osteoporosis]. Prier A Presse Med; 1989 Sep 2-9; 18(27):1317-9. PubMed ID: 2529491 [No Abstract] [Full Text] [Related]
18. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis. Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510 [TBL] [Abstract][Full Text] [Related]
19. Fluoride and bone: a second look. No use in osteoporosis. Prescrire Int; 1998 Aug; 7(36):110-1. PubMed ID: 10342949 [TBL] [Abstract][Full Text] [Related]
20. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride. Hedlund LR; Gallagher JC J Bone Miner Res; 1989 Apr; 4(2):223-5. PubMed ID: 2728925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]